Business

KDA Group Announces the Appointments of Sylvain Duvernay as Chief Executive Officer and Pierre Monet as Chief Financial Officer

(TheNewswire) Thetford Mines, Quebec - TheNewswire - October 15, 2020 ...

articleKda Group Inc.October 15, 20205/company/kda-group-inc/news/kda-group-announces-the-appointments-of-sylvain-duvernay-as-chief-executive-officer-and-pierre-monet-as-chief-financial-officer
KDA Group Announces the Appointments of Sylvain Duvernay as Chief Executive Officer and Pierre Monet as Chief Financial Officer

About this update from Kda Group Inc.

[{"type":"text","content":"KDA Group Announces the Appointments of Sylvain Duvernay as Chief Executive Officer and Pierre Monet as Chief Financial Officer\n \n \n (TheNewswire)\n \n \n \n Thetford Mines, Quebec\n \n \n -\n \n \n TheNewswire -\n \n \n October 15, 2020\n \n \n -\n \n \n KDA\n \n \n Group Inc.\n(TSXV:KDA) (\"\n \n \n KDA\n \n \n \" or the \"\n \n \n Corporation\n \n \n \") is\npleased to announce today the appointments of Mr. Sylvain Duvernay as\nChief Executive Officer of KDA and Mr. Pierre Monet as Chief Financial\nOfficer of the Corporation, effective immediately.\n \n \n \n \n Sylvain Duvernay\n \n \n - Mr. Duvernay holds a Bachelor's degree in Business\nAdministration and a Certificate in International Trade. He has over\n20 years of experience in pharmaceutical and international\nbusiness.\n \n \n \n \n Mr. Duvernay filled the position of Vice-President for\nStrides Arcolab Ltd a pharmaceutical generic product company involved\nin softgel, injectable and solid dose manufacturing. He led its\nCanadian operations as well as its business development in the United\nStates.\n \n \n \n \n In 2008, Sylvain was behind the acquisition of the\nBristol-Myers Squibb facility in Candiac where he developed a business\nmodel for the injectable business and acted as CEO of the new entity,\nUman Pharma Inc.\n \n \n \n \n The company was sold to Pharmascience in November 2014\nand for two years, Sylvain was Vice-President, Injectable Products and\nresponsible for the U.S. market, before moving to Capcium, a softgel\nmanufacturing company for the pharmaceutical and nutraceutical\nsectors.\n \n \n \n \n As Capcium's CEO, he led the strategy and the\nconstruction of a state-of-the-art facility that will meet FDA, EMA\nand Health Canada standards.\n \n \n \n \n Pierre Monet\n \n \n -\nMr. Monet has more than 35 years' experience in public and private\ncompanies at national and international levels. He has a solid\nbackground in finance combined with operations management.\n \n \n \n \n He has played key roles in mergers and acquisitions as\nwell as corporate restructuring. He has a strategic and\nresults-oriented mind.\n \n \n \n \n Mr. Monet holds a Bachelor's degree in Business\nAdministration from the Hautes Etudes Commerciales and is a Chartered\nProfessional Accountant (CPA).\n \n \n \n \n The Corporation's current Chief Executive Officer, Mr.\nMarc Le...

More updates from Kda Group Inc.